- Home
- BN
as 12-20-2024 4:00pm EST
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has three businesses Asset Management, Insurance Solutions, and Operating Businesses. it invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. It generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, and other countries.
| Founded: | 1997 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 75.3B | IPO Year: | N/A |
| Target Price: | $54.83 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $37.77 - $62.44 | Next Earning Date: | 02-06-2025 |
| Revenue: | $93,222,000,000 | Revenue Growth: | -4.42% |
| Revenue Growth (this year): | -94.65% | Revenue Growth (next year): | 16.37% |
Latest Brookfield Corporation Limited Voting Shares News
BN Breaking Stock News: Dive into BN Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
BN: What does Argus have to say about BN?
Bloomberg
9 days ago
Climate Tech Funds See Cash Pile Rise to $86 Billion as Investing Slows
Argus Research
11 days ago
BAM: Lowering target price to $62.00
GlobeNewswire
11 days ago
Brookfield Corporation Announces Pricing of $700 Million Subordinated Notes Due 2055
The Wall Street Journal
17 days ago
Neoen Agrees to Australian Asset Sale to Smooth Brookfield Takeover
Argus Research
18 days ago
BAM: Raising target price to $64.00
Argus Research
25 days ago
BAM: Raising target price to $63.00
TipRanks
a month ago
Here’s Why Super Investors are Loading Up on Brookfield Stock (NYSE:BN)
Compare BN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BN Brookfield Corporation Limited Voting Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.